These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 17243100)

  • 1. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
    Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
    J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
    Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
    Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
    Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.
    Seya T; Matsumoto M; Ebihara T; Oshiumi H
    Immunol Rev; 2009 Jan; 227(1):44-53. PubMed ID: 19120474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.
    Hardy MP; McGGettrick AF; O'Neill LA
    Biochem J; 2004 May; 380(Pt 1):83-93. PubMed ID: 14960149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
    Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
    Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
    Park SJ; Lee AN; Youn HS
    Arch Pharm Res; 2010 Jun; 33(6):939-45. PubMed ID: 20607500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guggulsterone suppresses the activation of transcription factor IRF3 induced by TLR3 or TLR4 agonists.
    Youn HS; Ahn SI; Lee BY
    Int Immunopharmacol; 2009 Jan; 9(1):108-12. PubMed ID: 19000789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.
    Matsumoto M; Kikkawa S; Kohase M; Miyake K; Seya T
    Biochem Biophys Res Commun; 2002 May; 293(5):1364-9. PubMed ID: 12054664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
    Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
    Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists.
    Youn HS; Lim HJ; Choi YJ; Lee JY; Lee MY; Ryu JH
    Int Immunopharmacol; 2008 Mar; 8(3):495-501. PubMed ID: 18279804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
    Youn HS; Saitoh SI; Miyake K; Hwang DH
    Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin.
    Lee JK; Kim SY; Kim YS; Lee WH; Hwang DH; Lee JY
    Biochem Pharmacol; 2009 Apr; 77(8):1391-400. PubMed ID: 19426678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells.
    Nakada E; Walley KR; Nakada T; Hu Y; von Dadelszen P; Boyd JH
    Placenta; 2009 Sep; 30(9):774-9. PubMed ID: 19631980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
    Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
    Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction.
    Takaki H; Oshiumi H; Sasai M; Kawanishi T; Matsumoto M; Seya T
    Eur J Immunol; 2009 Dec; 39(12):3469-76. PubMed ID: 19795416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.